Clinical Trial Update: Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices [Phase 4]

View source ↗

Summary

Phase 4 trial update for primary prevention in patients with hepatocellular carcinoma and concomitant esophageal varices.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding Esophageal Varices
• Hepatocellular Carcinoma

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Bleeding Esophageal Varices, Hepatocellular Carcinoma | Phase 4 | Status: UNKNOWN